Dmitry Borkin

This inventor holds 16 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: University of Michigan, Kura Oncology, Inc., Cellerant Therapeutics, Inc.. Active years: 2015-2024.

USPTO Granted Patents = 16 (Patent Applications = 7)

% Patents Active = 93.8

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 5 (Patent Applications = 11)

Average Co-Inventor Count = 8.2

ph-index = 8

Forward Citations = 150(Granted Patents)

Location History:

Feasterville, PA (US) (2019 - 2023)
Ann Arbor, MI (US) (2015 - 2024)

Company Filing History:

15 out of 3,523

University of Michigan

Cellerant Therapeutics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2015-2024

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11883381 - ASH1L inhibitors and methods of treatment therewith (2024-01-30),

2. RE49687 - Thienopyrimidine and thienopyridine compounds and methods of use thereof (2023-10-10),

3. 11673898 - Substituted inhibitors of menin-MLL and methods of use (2023-06-13),

4. 11555041 - Bridged bicyclic inhibitors of menin-MLL and methods of use (2023-01-17),

5. 11542248 - Methods and compositions for inhibiting the interaction of menin with MLL proteins (2023-01-03),

6. 10781218 - Substituted inhibitors of menin-MLL and methods of use (2020-09-22),

7. 10752639 - Bridged bicyclic inhibitors of menin-MLL and methods of use (2020-08-25),

8. 10588907 - Methods and compositions for inhibiting the interaction of menin with MLL proteins (2020-03-17),

9. 10350218 - Isoquinolidinobenzodiazepine (IQB)-1(chloromethyl)-2,3-dihydro-1H-benzo[e]indole (CBI) dimers (2019-07-16),

10. 10246464 - Thienopyrimidine and thienopyridine compounds and methods of use thereof (2019-04-02),

11. 10174041 - Methods and compositions for inhibiting the interaction of menin with MLL proteins (2019-01-08),

12. 10160769 - Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof (2018-12-25),

13. 10077271 - Methods and compositions for inhibiting the interaction of menin with MLL proteins (2018-09-18),

14. 9505782 - Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof (2016-11-29),

15. 9505781 - Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof (2016-11-29),

Title: Inventor Dmitry Borkin: Revolutionizing Technology in Ann Arbor

Introduction: Dmitry Borkin is a visionary inventor based in Ann Arbor, MI, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Dmitry Borkin holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Dmitry Borkin has worked with leading tech companies and research institutions, consistently pushing the boundaries of what is possible in the realm of technological advancement.

Collaborations: Throughout his career, Dmitry Borkin has collaborated with top engineers, scientists, and researchers, fostering a culture of innovation and creativity that has led to numerous successful projects and inventions.

Conclusion: Dmitry Borkin's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology in Ann Arbor and beyond.